Evidence map›Paper›PMID 21791200›Full record

ArticleBiochimica et biophysica acta2011

Multi-Tox: application of the ToxR-transcriptional reporter assay to the study of multi-pass protein transmembrane domain oligomerization.

Catherine Joce, Alyssa A Wiener, Hang Yin

Abstract read
In one paragraph

Article in Biochimica et biophysica acta, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Drugging Membrane Protein Interactions.Annual review of biomedical engineering · 2016
    Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Catherine JoceDepartment of Chemistry and Biochemistry, University of Colorado at Boulder, Boulder, CO 80309-0215, USA.
Alyssa A Wiener
Hang Yin

Funding

Probing EBV-LMP-1's Transmembrane Activation Domain with Synthetic Peptide AntagoR21CA138373 · NCI · UNIVERSITY OF COLORADO · PI MARTIN, JENNIFER M, YIN, HANG HUBERT · 2009 to 2010
$626k
NCI NIH HHS R21 CA138373NCI NIH HHS R21CA138373
6 · The paper itself

Abstract

ToxR-based transcriptional reporter assays allow the strength of transmembrane helix interactions in biological membranes to be measured. Previously, these assays have only been used to study single-pass transmembrane systems. To facilitate investigation of polytopic transmembrane domain (TMD) oligomerization, we applied the ToxR methodology to the study of multi-pass TMD oligomerization to give 'Multi-Tox'. Association propensities of the viral oncoprotein, latent membrane protein-1 (LMP-1), and the E. coli membrane-integral diacylglycerol kinase (DAGK) were studied by Multi-Tox, highlighting residues of particular mechanistic importance. Both homo- and hetero-oligomerizations were studied.

Indexed as

Genes, ReporterTranscription, GeneticBacterial ProteinsBiopolymersDiacylglycerol KinaseDNA-Binding ProteinsEscherichia coliMembrane ProteinsTranscription FactorsBacterial ProteinsBiopolymersDiacylglycerol KinaseDNA-Binding ProteinsMembrane ProteinstoxR protein, bacteriaTranscription Factors

Identifiers

PMID21791200
PMCPMC3195870

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.